Nikki Zite
Obstetrics & Gynecology · Knoxville, TNNPI 1518065416
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 49.4% of the total. Reporting peaked in 2020 at $4,822 and has fallen 99.0% since, to $47 in 2025. Among obstetrics & gynecology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $335.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$5K
- Organon$3K
- Mylan Specialty L.p.$1K
- Axonics, Inc.$325
- Merck$115
- Baxter Healthcare$66
- plus $159 from 7 others
Across 38 payments — averaging $5725.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$168K
- Bayer$26K
- Medicines360$22K
- Organon$1K
What the payments were for
- Consulting fees$5,82060%
- Speaking & faculty fees$2,88630%
- Food & beverage$99910%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 2 | $4,800 |
| Organon | 7 | $3,232 |
| Mylan Specialty L.p. | 1 | $1,020 |
| Axonics, Inc. | 4 | $325 |
| Merck | 5 | $115 |
| Baxter Healthcare | 2 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Conmed Corporation | 1 | $25 |
| AbbVie | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Bayer | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $11 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXTSTELLIS$4,800
- NEXPLANON$3,011
- Xulane$1,020
- Bulkamid$243
- Axonics$243
- IMPLANON$125
How this compares
$9,716 in reported general payments places this provider in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $988 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Knoxville
- Larry FieldsKnoxville$323K
- Ramona ScottKnoxville$25K
- Lowell McCauleyKnoxville$21K
- Michael BullenKnoxville$13K
- Rosalind CadiganKnoxville$10K
- Kimberly RobertsKnoxville$9K
- Sudha NairKnoxville$8K
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
- Brent LaingElizabethton$480K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.